The influence of the aldosterone-antagonist spironolactone on myocardial contractility.
D000818:Animals; D002302:Cardiac Output / Q000187:drug effects; D002415:Cats; D004305:Dose-Response Relationship, Drug; D006321:Heart / Q000187:drug effects*; D009119:Muscle Contraction / Q000187:drug effects; D009129:Muscle Tonus / Q000187:drug effects; D010210:Papillary Muscles / Q000187:drug effects*; D011188:Potassium / Q000494:pharmacology; D012964:Sodium / Q000494:pharmacology; D013148:Spironolactone / Q000008:administration & dosage / Q000494:pharmacology*
D013148:Spironolactone; D012964:Sodium; D011188:Potassium